KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
80 hedge funds and large institutions have $640M invested in Kalaris Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 15 closing their positions.
Holders
80
Holders Change
-4
Holders Change %
-4.76%
% of All Funds
1.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
29
Reduced
23
Closed
15
Calls
$1.33M
Puts
$2K
Net Calls
+$1.33M
Net Calls Change
+$1.33M